GAO: U.S. Screwworm Outbreak Tops 100 Cases, Spurs Debate Over Gene-Drive Tools
A resurging New World screwworm outbreak in the United States has now topped 100 cases, according to a Government Accountability Office report released Tuesday, sharpening pressure on agriculture officials to consider newer genetic control tools because the traditional sterile-fly response may not be enough on its own.
In its “Science & Tech Spotlight: New World Screwworm Eradication,” published Nov. 18 as GAO-27-109347, the congressional watchdog said, “Over 100 total cases have been identified in the U.S. as of November 2026.” The report frames the outbreak as more than a livestock health emergency. It is also a policy test over whether the U.S. should move beyond a proven eradication method and toward more powerful biotechnology that carries unresolved regulatory and ethical questions.
The stakes are high for ranchers and the broader farm economy. New World screwworm is a parasitic fly whose larvae infest open wounds in cattle, sheep and other animals, causing severe injury and sometimes death if untreated. GAO said the pest could cost the U.S. cattle industry billions of dollars per year. The public health risk is much lower: The Centers for Disease Control and Prevention says the risk of human infection in the United States is “very low.”
The current U.S. outbreak was first confirmed June 3, when the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service, or APHIS, identified infection in a calf in Zavala County, Texas. The species was eradicated from the United States in 1966, largely through the sterile insect technique, and for decades a barrier program in Panama has been central to preventing its return from farther south.
That technique works by mass-rearing screwworm flies in a secure facility, sterilizing them with radiation and releasing them into the environment. Sterile males then mate with wild females, which generally mate only once and produce no offspring. GAO said the method is mature and proven, but inefficient because conventional production also generates females that are not useful for suppression. A jointly funded facility in Panama releases about 100 million sterile flies per week to maintain a biological barrier against northward spread from South America. That barrier was breached in 2023, and USDA in 2026 began releasing sterile flies in the United States and Mexico in response to the current outbreak.
GAO points to two newer genetic approaches that could make suppression more effective, while stressing that they are not the same thing. One is a genetically engineered male-only strain, designed so female offspring die during production, leaving only males for release. APHIS says the strain relevant to the U.S. response is NovoFly, developed by the USDA’s Agricultural Research Service with North Carolina State University. Because only males are reared for release, the system can save feed, energy and facility space and improve efficiency.
Crucially, NovoFly is still used within the existing sterile insect program, not as a self-sustaining release. APHIS said the flies are irradiated before release to ensure sterility. The agency said, “EPA has evaluated the safety of NovoFlyTM and its use in USDA’s Sterile Insect Release program under its regulations and issued an emergency use exemption under Section 18 of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) … on June 8, 2026, subject to conditions set forth in the authorization letter.” EPA also published a proposed Section 3 registration decision in June.
The second approach is far more consequential: gene drives, genetic systems designed to spread through wild populations and suppress or eliminate a species. GAO said gene drives have shown population suppression in caged mosquito trials. For New World screwworm, however, they have not been used in the wild. GAO said Uruguay has approved caged trials involving screwworm gene-drive work.
That distinction matters because the regulatory and policy questions are much larger for gene drives than for male-only sterile releases. GAO said the U.S. regulatory environment for gene drives is uncertain and highlighted broader concerns about governance, the possibility of resistance, cross-border impacts and whether deliberately driving a species extinct is justified.
For now, the outbreak is forcing a practical decision as much as a scientific one: whether the U.S. can contain screwworm with an upgraded version of a decades-old eradication playbook, or whether a worsening livestock threat will push policymakers toward genetic biocontrol tools that go much further.